(AFX UK Focus) 2010-05-18 13:51 UPDATE 1-Allos bladder cancer drug gets orphan status
May 18 (Reuters) – Allos Therapeutics Inc said its experimental bladder cancer drug received an orphan drug status from the U.S. health regulator, sending its shares up 8 percent in pre-market.

Read more on Interactive Investor